"10.1371_journal.pone.0048259","plos one","2012-10-26T00:00:00Z","Sarosh Rana; Ana Sofia Cerdeira; Julia Wenger; Saira Salahuddin; Kee-Hak Lim; Steven J Ralston; Ravi I Thadhani; S Ananth Karumanchi","Division of Maternal Fetal Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America; Gulbenkian Programme for Advanced Medical Education, Lisbon, Portugal; Division of Nephrology/Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Boston Maternal Fetal Medicine Group, Boston, Massachusetts, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America","Conceived and designed the experiments: SR ASC SS RT SAK. Performed the experiments: SR SS. Analyzed the data: JW RT. Contributed reagents/materials/analysis tools: RT SAK. Wrote the paper: SR ASC JW KHL SJR RT SAK. Consented and collected all samples: SS.","The authors have read the journals policy and have the following conflicts: Dr. Karumanchi is co-inventor on multiple patents (USPTO #7,740,849, #7,407,658, #7,335,362, #7,344,892) related to the use of angiogenic markers for the diagnosis, prediction and therapy of preeclampsia). Dr. Karumanchi reports having served as a consultant to Roche and Beckman Coulter and has financial interest in Aggamin LLC. Dr. Thadhani is a co-inventor on a patent (USPTO #7,344,892) related to the use of angiogenic proteins for the prediction of preeclampsia and has financial interest in Aggamin LLC.","2012","10","Sarosh Rana","SR",8,TRUE,5,2,2,7,TRUE,FALSE,FALSE,0,NA,FALSE
